Cargando…
Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints
Glaucoma clinical trials using visual field (VF) endpoints currently require large sample sizes because of the slowly-progressive nature of this disease. We sought to examine whether the combined use of VF testing and non-invasive optical coherence tomography (OCT) imaging of the neuroretinal tissue...
Autores principales: | Wu, Zhichao, Medeiros, Felipe A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906445/ https://www.ncbi.nlm.nih.gov/pubmed/31827169 http://dx.doi.org/10.1038/s41598-019-55345-x |
Ejemplares similares
-
Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials
por: Wu, Zhichao, et al.
Publicado: (2018) -
Spectral-Domain Optical Coherence Tomography for Glaucoma Diagnosis
por: Gracitelli, Carolina P.B, et al.
Publicado: (2015) -
The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression
por: Abe, Ricardo Y, et al.
Publicado: (2015) -
Optical Coherence Tomography in Glaucoma
por: Sathyan, P, et al.
Publicado: (2012) -
Optical coherence tomography angiography in glaucoma: analysis of the vessel density—visual field sensitivity relationship
por: Holló, Gábor
Publicado: (2020)